These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 9555805)
1. A case of cicatricial pemphigoid with simultaneous IgG autoantibodies against the 180 kd bullous pemphigoid antigen and laminin 5. Kawahara Y; Amagai M; Ohata Y; Ishii K; Hasegawa Y; Hsu R; Yee C; Yancey KB; Nishikawa T J Am Acad Dermatol; 1998 Apr; 38(4):624-7. PubMed ID: 9555805 [No Abstract] [Full Text] [Related]
2. Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180. Schmidt E; Skrobek C; Kromminga A; Hashimoto T; Messer G; Bröcker EB; Yancey KB; Zillikens D Br J Dermatol; 2001 Nov; 145(5):778-83. PubMed ID: 11736901 [TBL] [Abstract][Full Text] [Related]
3. Four Japanese patients with cicatricial pemphigoid showing both IgG and IgA antibodies against the 180 kDa bullous pemphigoid antigen. Hashimoto T; Han-Yaku H; Higashiyama M; Hashimoto K; Iwatsuki K; Kaneko F; Murakami H; Nishikawa T Br J Dermatol; 1997 Aug; 137(2):305-6. PubMed ID: 9292089 [No Abstract] [Full Text] [Related]
4. The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis. Roh JY; Yee C; Lazarova Z; Hall RP; Yancey KB Br J Dermatol; 2000 Jul; 143(1):104-11. PubMed ID: 10886143 [TBL] [Abstract][Full Text] [Related]
5. Analysis of antigens targeted by circulating IgG and IgA antibodies in patients with mucous membrane pemphigoid predominantly affecting the oral cavity. Carrozzo M; Cozzani E; Broccoletti R; Carbone M; Pentenero M; Arduino P; Parodi A; Gandolfo S J Periodontol; 2004 Oct; 75(10):1302-8. PubMed ID: 15562906 [TBL] [Abstract][Full Text] [Related]
6. Cicatricial pemphigoid with circulating autoantibodies to beta4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230. Leverkus M; Bhol K; Hirako Y; Pas H; Sitaru C; Baier G; Bröcker EB; Jonkman MF; Ahmed AR; Zillikens D Br J Dermatol; 2001 Dec; 145(6):998-1004. PubMed ID: 11899157 [TBL] [Abstract][Full Text] [Related]
7. Autoantibodies from patients with localized and generalized bullous pemphigoid immunoprecipitate the same 230-kd keratinocyte antigen. Domloge-Hultsch N; Utecht L; James W; Yancey KB Arch Dermatol; 1990 Oct; 126(10):1337-41. PubMed ID: 2221940 [TBL] [Abstract][Full Text] [Related]
9. Acute blistering disease presenting IgG autoantibodies against NC16A and COOH-terminal domains of BP180 and laminin-332, with characteristic distribution of eruptions. Kurashige Y; Minemura T; Nagatani T; Koga H; Hashimoto T Eur J Dermatol; 2013; 23(1):109-10. PubMed ID: 23306276 [No Abstract] [Full Text] [Related]
10. A highly sensitive and simple assay for the detection of circulating autoantibodies against full-length bullous pemphigoid antigen 180. Schmidt E; Kromminga A; Mimietz S; Leinfelder U; Sitaru C; Bröcker EB; Zillikens D; Zimmermann U J Autoimmun; 2002 Jun; 18(4):299-309. PubMed ID: 12144811 [TBL] [Abstract][Full Text] [Related]
11. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity. Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100 [TBL] [Abstract][Full Text] [Related]
12. Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. Balding SD; Prost C; Diaz LA; Bernard P; Bedane C; Aberdam D; Giudice GJ J Invest Dermatol; 1996 Jan; 106(1):141-6. PubMed ID: 8592065 [TBL] [Abstract][Full Text] [Related]
13. Case of pemphigoid involving skin and mucous membrane with immunoglobulin G autoantibodies targeted to BP180 and laminin-332. Hosoda S; Suzuki M; Komine M; Fujita E; Yamada T; Murata S; Koga H; Hashimoto T; Ohtsuki M J Dermatol; 2013 Dec; 40(12):1067-8. PubMed ID: 24330181 [No Abstract] [Full Text] [Related]
14. IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230. Skaria M; Jaunin F; Hunziker T; Riou S; Schumann H; Bruckner-Tuderman L; Hertl M; Bernard P; Saurat JH; Favre B; Borradori L J Invest Dermatol; 2000 May; 114(5):998-1004. PubMed ID: 10771483 [TBL] [Abstract][Full Text] [Related]
15. Assessment of skin basement membrane zone antibodies in the urine of patients with acquired subepidermal immunobullous diseases. Allen J; Shears E; Powell J; Wojnarowska F Br J Dermatol; 2001 Mar; 144(3):540-5. PubMed ID: 11260011 [TBL] [Abstract][Full Text] [Related]
16. IgG autoantibodies from a lichen planus pemphigoides patient recognize the NC16A domain of the bullous pemphigoid antigen 180. Skaria M; Salomon D; Jaunin F; Friedli A; Saurat JH; Borradori L Dermatology; 1999; 199(3):253-5. PubMed ID: 10592407 [TBL] [Abstract][Full Text] [Related]
17. Concurrence of autoantibodies to bullous pemphigoid antigens and desmoglein 3: analysis of pathogenic and nonpathogenic antibodies. Ono S; Tanioka M; Tanizaki H; Fujisawa A; Koga H; Hashimoto T; Kamiya K; Aoyama Y; Iwatsuki K; Miyachi Y Br J Dermatol; 2013 Jun; 168(6):1357-60. PubMed ID: 23738642 [No Abstract] [Full Text] [Related]
18. IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis. Christophoridis S; Büdinger L; Borradori L; Hunziker T; Merk HF; Hertl M Br J Dermatol; 2000 Aug; 143(2):349-55. PubMed ID: 10951144 [TBL] [Abstract][Full Text] [Related]
19. Mucous membrane pemphigoid with immunoglobulin G autoantibodies against full-length and 120-kDa ectodomain of BP180. Choi Y; Lee SE; Fukuda S; Hashimoto T; Kim SC J Dermatol; 2011 Feb; 38(2):169-72. PubMed ID: 21269314 [TBL] [Abstract][Full Text] [Related]
20. Immunofluorescence-negative bullous pemphigoid sera contain antibodies mostly directed against the 180 kDa bullous pemphigoid antigen (BPAg2). Ghohestani RF; Claudy A Br J Dermatol; 1997 Aug; 137(2):306-7. PubMed ID: 9292090 [No Abstract] [Full Text] [Related] [Next] [New Search]